Pharmacotherapy Exam 1 September 27: Lecture 2 - Introduction To Autonomic Etc

12 Questions

Settings
Please wait...
Pharmacology Quizzes & Trivia

Creighton University Nursing Pharmacotherapy exam 1 learning quiz. This quiz might NOT simulate any case/scenario exam questions. Rather, it is only meant to reinforce the basics and the details that exam scenario questions would be built on. So as not to discourage anyone from adding good questions, let's just say that as long as you are close in the "fill in the blanks" answers (you decide) count yourself right. Otherwise, the question creator will have to try to think of every possible way a quiz taker might type in a right answer, and that is too much to require of us.


Questions and Answers
  • 1. 
    Mark the characteristics of the SOMATIC nervous system
    • A. 

      Ganglions nearer to the effectors

    • B. 

      Ganglions nearer to the spinal cord

    • C. 

      One neuron chain, no ganglion, no hormones

    • D. 

      One neuron chain, no ganglion, epinephrine and norepinephrine hormones

    • E. 

      α receptors on some or all effectors

    • F. 

      β receptors on some or all effectors

    • G. 

      Muscarinic receptors on some or all effectors

    • H. 

      Nicotinic receptors on some or all effectors

    • I. 

      Nerves exit spinal cord only in cranial and sacral regions

    • J. 

      Nerves exit spinal cord only in thoracic and lumbar regions

    • K. 

      Norepinephrine used in at least one junction or synapse

    • L. 

      Dopamine used in at least one junction or synapse

    • M. 

      Acetylcholine used in at least one junction or synapse

  • 2. 
    Mark the characteristics of the SYMPATHOADRENAL nervous system
    • A. 

      Ganglions nearer to the effectors

    • B. 

      Ganglions nearer to the spinal cord

    • C. 

      One neuron chain, no ganglion, no hormones

    • D. 

      One neuron chain, no ganglion, epinephrine and norepinephrine hormones

    • E. 

      α receptors on some or all effectors

    • F. 

      β receptors on some or all effectors

    • G. 

      Muscarinic receptors on some or all effectors

    • H. 

      Nicotinic receptors on some or all effectors

    • I. 

      Nerves exit spinal cord only in cranial and sacral regions

    • J. 

      Nerves exit spinal cord only in thoracic and lumbar regions

    • K. 

      Norepinephrine used in at least one junction or synapse

    • L. 

      Dopamine used in at least one junction or synapse

    • M. 

      Acetylcholine used in at least one junction or synapse

  • 3. 
    Mark the characteristics of the SYMPATHETIC nervous system (but not including the sympathoadrenal NS)
    • A. 

      Ganglions nearer to the effectors

    • B. 

      Ganglions nearer to the spinal cord

    • C. 

      One neuron chain, no ganglion, no hormones

    • D. 

      One neuron chain, no ganglion, epinephrine and norepinephrine hormones

    • E. 

      α receptors on some or all effectors

    • F. 

      β receptors on some or all effectors

    • G. 

      Muscarinic receptors on some or all effectors

    • H. 

      Nicotinic receptors on some or all effectors

    • I. 

      Nerves exit spinal cord only in cranial and sacral regions

    • J. 

      Nerves exit spinal cord only in thoracic and lumbar regions

    • K. 

      Norepinephrine used in at least one junction or synapse

    • L. 

      Dopamine used in at least one junction or synapse

    • M. 

      Acetylcholine used in at least one junction or synapse

  • 4. 
    Mark the characteristics of the PARASYMPATHETIC nervous system
    • A. 

      Ganglions nearer to the effectors

    • B. 

      Ganglions nearer to the spinal cord

    • C. 

      One neuron chain, no ganglion, no hormones

    • D. 

      One neuron chain, no ganglion, epinephrine and norepinephrine hormones

    • E. 

      α receptors on some or all effectors

    • F. 

      β receptors on some or all effectors

    • G. 

      Muscarinic receptors on some or all effectors

    • H. 

      Nicotinic receptors on some or all effectors

    • I. 

      Nerves exit spinal cord only in cranial and sacral regions

    • J. 

      Nerves exit spinal cord only in thoracic and lumbar regions

    • K. 

      Norepinephrine used in at least one junction or synapse

    • L. 

      Dopamine used in at least one junction or synapse

    • M. 

      Acetylcholine used in at least one junction or synapse

  • 5. 
    According to the handout, the synapse neurotransmitter common to ALL neurons exiting the spinal cord toward their synapses, whether in ganglions or at effector organs is:
    • A. 

      Acetylcholine

    • B. 

      Norepinephrine

  • 6. 
    According to the handout, ALL the neurons in the systems we have discussed synapse to junctions that are [muscarinic/nicotinic] except for the ones junctioning to ____________________ at their distal ends.
    • A. 

      Muscarinic

    • B. 

      Nicotinic

    • C. 

      Cholinergic smooth and cardiac muscle, glands

    • D. 

      Adrenergic smooth and cardiac muscle, glands

    • E. 

      Skeletal muscles

    • F. 

      Sympathetic ganglions

    • G. 

      Parasympathetic ganglions

    • H. 

      Both types autonomic ganglions

    • I. 

      Adrenal medulla

  • 7. 
    The parasympathetic effector junctions are ALL to what type of receptors?
    • A. 

      Muscalinic

    • B. 

      Nicotinic

  • 8. 
       The following are characteristics of which system?Eye – miosis, lens focused for near visionExocrine glands – (lacrimal, mucous, salivary etc.)- increased secretionsLung – bronchoconstrictionHeart – decreased heart rateGastrointestinal tract – increased gastric acid and increased motilityUrinary bladder – increased urinationMale sex organs – erection
    • A. 

      Parasympathetic

    • B. 

      Sympathetic

  • 9. 
    The more common function that β2 receptors have on their effector organs is
    • A. 

      Dilation/relaxation

    • B. 

      Constriction/toning

  • 10. 
    Most commonly, if the drug name ends in "-olol", it is a _________-blocker.
  • 11. 
    Most commonly, if a drug name ends in "-alol", it is a combined _________ and ________ blocker.
  • 12. 
    Select all the direct-acting muscarinic receptor agonists
    • A. 

      Acetylcholine

    • B. 

      Cevimeline

    • C. 

      Carbachol

    • D. 

      Bethanechol

    • E. 

      Pilocarpine

    • F. 

      Muscarine